» Articles » PMID: 16722926

Observer Variation in Immunohistochemical Analysis of Protein Expression, Time for a Change?

Overview
Journal Histopathology
Date 2006 May 26
PMID 16722926
Citations 110
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Immunohistochemical analysis of protein expression is central to most clinical translational studies and defines patient treatment or selection criteria for novel drugs. Interobserver variation is rarely analysed despite recognition that this is a key area of potential inaccuracy. Therefore our aim was to examine observer variation and suggest the revision of current standards.

Methods And Results: We analysed inter- and intra-observer variation, by interclass correlation coefficient (ICCC) and kappa statistics, in 8661 samples. Intra-observer assessment of nuclear, cytoplasmic and membrane staining for seven proteins in 1323 samples resulted in an ICCC of 0.94 and a kappa-value of 0.787. Interobserver reproducibility, assessed on 28 proteins by seven observer pairs in 8661 carcinomas, gave an ICCC of 0.90 and a kappa-value of 0.70. No significant effect of either antibody or cellular compartmentalization was observed.

Conclusion: We have demonstrated that ICCC is a consistent method to assess observer variation when a continuous scoring system is used, compared with kappa statistics, which depends on a categorical system. Given the importance of accurate assessment of protein expression in diagnostic and experimental medicine, we suggest raising thresholds for observer variation: ICCC of 0.7 should be regarded as the minimum acceptable standard, ICCC of 0.8 as good and ICCC of > or = 0.9 as excellent.

Citing Articles

Retrospective evaluation of a novel ultrasound-based imaging analysis software for predicting radiofrequency ablation areas.

Sato M, Tateishi R, Zohar Y, Sato J, Watadani T, Moriyama M PLoS One. 2025; 20(1):e0317469.

PMID: 39823502 PMC: 11741625. DOI: 10.1371/journal.pone.0317469.


Deep learning for automated scoring of immunohistochemically stained tumour tissue sections - Validation across tumour types based on patient outcomes.

Kildal W, Cyll K, Kalsnes J, Islam R, Julbo F, Pradhan M Heliyon. 2024; 10(13):e32529.

PMID: 39040241 PMC: 11261074. DOI: 10.1016/j.heliyon.2024.e32529.


Feasibility study of ADCs targeting TROP-2, HER2, and CD46 in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate.

Wang X, Qi L, Chen M, Zhang Y, Gao X, Cai Y World J Urol. 2024; 42(1):404.

PMID: 38990246 DOI: 10.1007/s00345-024-05109-8.


The combined tumour-based Fascin/Snail and stromal periostin reveals the effective prognosis prediction in colorectal cancer patients.

Jirapongwattana N, Thongchot S, Pongpaibul A, Trakarnsanga A, Quinn J, Thuwajit P PLoS One. 2024; 19(6):e0304666.

PMID: 38935747 PMC: 11210851. DOI: 10.1371/journal.pone.0304666.


MRI and PET imaging in a translational ILD mouse model expressing non-resolving fibrosis and bronchiectasis-like pathology after repeated systemic exposure to bleomycin.

Mahmutovic Persson I, Fransen Petterson N, Liu J, In t Zandt R, Carvalho C, Orbom A Front Med (Lausanne). 2024; 11:1276420.

PMID: 38654839 PMC: 11035813. DOI: 10.3389/fmed.2024.1276420.